Inactivation of heparin during extracorporeal circulation in infants

Thomas P. Green, Barbara Isham-Schopf, Richard J. Irmiter, Clark Smith, Donald L. Uden, Robin H Steinhorn

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Heparin anticoagulation is necessary to prevent clotting during procedures involving the extracorporeal circulation of blood. Our preliminary observations suggested that heparin was inactivated in the extracorporeal circuit during extracorporeal membrane oxygenation. We tested this hypothesis by comparing heparin pharmacokinetics in five infants during extracorporeal circulation with kinetics, respectively determined in each patient and in the isolated circuit immediately after discontinuation of the procedure. Heparin clearance was 1.6 ± 0.5 ml/kg/min in the patient and 2.1 ± 0.8 ml/kg/min in the separated circuit. In each patient, the total of heparin clearances in the patient and circuit, 3.7 ± 1.0 ml/kg/min, was virtually identical with the heparin clearance during the procedure, 3.8 ± 1.9 ml/kg/min (r = 0.94, p < 0.01). We conclude that more than one half of the heparin administered to infants during extracorporeal membrane oxygenation is eliminated by the extracorporeal circuit itself or by blood components in the circuit. These data explain the relatively large heparin doses needed to maintain anticoagulation in infants during extracorporeal circulation. In light of these findings, a reexamination of the normal mechanisms of elimination of heparin activity appears to be warranted.

Original languageEnglish (US)
Pages (from-to)148-154
Number of pages7
JournalClinical Pharmacology and Therapeutics
Volume48
Issue number2
StatePublished - Aug 1990
Externally publishedYes

Fingerprint

Extracorporeal Circulation
Heparin
Extracorporeal Membrane Oxygenation
Pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Green, T. P., Isham-Schopf, B., Irmiter, R. J., Smith, C., Uden, D. L., & Steinhorn, R. H. (1990). Inactivation of heparin during extracorporeal circulation in infants. Clinical Pharmacology and Therapeutics, 48(2), 148-154.

Inactivation of heparin during extracorporeal circulation in infants. / Green, Thomas P.; Isham-Schopf, Barbara; Irmiter, Richard J.; Smith, Clark; Uden, Donald L.; Steinhorn, Robin H.

In: Clinical Pharmacology and Therapeutics, Vol. 48, No. 2, 08.1990, p. 148-154.

Research output: Contribution to journalArticle

Green, TP, Isham-Schopf, B, Irmiter, RJ, Smith, C, Uden, DL & Steinhorn, RH 1990, 'Inactivation of heparin during extracorporeal circulation in infants', Clinical Pharmacology and Therapeutics, vol. 48, no. 2, pp. 148-154.
Green TP, Isham-Schopf B, Irmiter RJ, Smith C, Uden DL, Steinhorn RH. Inactivation of heparin during extracorporeal circulation in infants. Clinical Pharmacology and Therapeutics. 1990 Aug;48(2):148-154.
Green, Thomas P. ; Isham-Schopf, Barbara ; Irmiter, Richard J. ; Smith, Clark ; Uden, Donald L. ; Steinhorn, Robin H. / Inactivation of heparin during extracorporeal circulation in infants. In: Clinical Pharmacology and Therapeutics. 1990 ; Vol. 48, No. 2. pp. 148-154.
@article{278a135b9bd14292bf425f13417d2c6e,
title = "Inactivation of heparin during extracorporeal circulation in infants",
abstract = "Heparin anticoagulation is necessary to prevent clotting during procedures involving the extracorporeal circulation of blood. Our preliminary observations suggested that heparin was inactivated in the extracorporeal circuit during extracorporeal membrane oxygenation. We tested this hypothesis by comparing heparin pharmacokinetics in five infants during extracorporeal circulation with kinetics, respectively determined in each patient and in the isolated circuit immediately after discontinuation of the procedure. Heparin clearance was 1.6 ± 0.5 ml/kg/min in the patient and 2.1 ± 0.8 ml/kg/min in the separated circuit. In each patient, the total of heparin clearances in the patient and circuit, 3.7 ± 1.0 ml/kg/min, was virtually identical with the heparin clearance during the procedure, 3.8 ± 1.9 ml/kg/min (r = 0.94, p < 0.01). We conclude that more than one half of the heparin administered to infants during extracorporeal membrane oxygenation is eliminated by the extracorporeal circuit itself or by blood components in the circuit. These data explain the relatively large heparin doses needed to maintain anticoagulation in infants during extracorporeal circulation. In light of these findings, a reexamination of the normal mechanisms of elimination of heparin activity appears to be warranted.",
author = "Green, {Thomas P.} and Barbara Isham-Schopf and Irmiter, {Richard J.} and Clark Smith and Uden, {Donald L.} and Steinhorn, {Robin H}",
year = "1990",
month = "8",
language = "English (US)",
volume = "48",
pages = "148--154",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Inactivation of heparin during extracorporeal circulation in infants

AU - Green, Thomas P.

AU - Isham-Schopf, Barbara

AU - Irmiter, Richard J.

AU - Smith, Clark

AU - Uden, Donald L.

AU - Steinhorn, Robin H

PY - 1990/8

Y1 - 1990/8

N2 - Heparin anticoagulation is necessary to prevent clotting during procedures involving the extracorporeal circulation of blood. Our preliminary observations suggested that heparin was inactivated in the extracorporeal circuit during extracorporeal membrane oxygenation. We tested this hypothesis by comparing heparin pharmacokinetics in five infants during extracorporeal circulation with kinetics, respectively determined in each patient and in the isolated circuit immediately after discontinuation of the procedure. Heparin clearance was 1.6 ± 0.5 ml/kg/min in the patient and 2.1 ± 0.8 ml/kg/min in the separated circuit. In each patient, the total of heparin clearances in the patient and circuit, 3.7 ± 1.0 ml/kg/min, was virtually identical with the heparin clearance during the procedure, 3.8 ± 1.9 ml/kg/min (r = 0.94, p < 0.01). We conclude that more than one half of the heparin administered to infants during extracorporeal membrane oxygenation is eliminated by the extracorporeal circuit itself or by blood components in the circuit. These data explain the relatively large heparin doses needed to maintain anticoagulation in infants during extracorporeal circulation. In light of these findings, a reexamination of the normal mechanisms of elimination of heparin activity appears to be warranted.

AB - Heparin anticoagulation is necessary to prevent clotting during procedures involving the extracorporeal circulation of blood. Our preliminary observations suggested that heparin was inactivated in the extracorporeal circuit during extracorporeal membrane oxygenation. We tested this hypothesis by comparing heparin pharmacokinetics in five infants during extracorporeal circulation with kinetics, respectively determined in each patient and in the isolated circuit immediately after discontinuation of the procedure. Heparin clearance was 1.6 ± 0.5 ml/kg/min in the patient and 2.1 ± 0.8 ml/kg/min in the separated circuit. In each patient, the total of heparin clearances in the patient and circuit, 3.7 ± 1.0 ml/kg/min, was virtually identical with the heparin clearance during the procedure, 3.8 ± 1.9 ml/kg/min (r = 0.94, p < 0.01). We conclude that more than one half of the heparin administered to infants during extracorporeal membrane oxygenation is eliminated by the extracorporeal circuit itself or by blood components in the circuit. These data explain the relatively large heparin doses needed to maintain anticoagulation in infants during extracorporeal circulation. In light of these findings, a reexamination of the normal mechanisms of elimination of heparin activity appears to be warranted.

UR - http://www.scopus.com/inward/record.url?scp=0024996520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024996520&partnerID=8YFLogxK

M3 - Article

C2 - 2379386

AN - SCOPUS:0024996520

VL - 48

SP - 148

EP - 154

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -